To The Moon
Home
News
TigerAI
Log In
Sign Up
Snoopdog
+Follow
Posts · 155
Posts · 155
Following · 0
Following · 0
Followers · 0
Followers · 0
Snoopdog
Snoopdog
·
2023-09-09
$American Battery Technology Company(ABML)$
Can't buy this stock on Tiger now :(
看
2.13K
回复
Comment
点赞
1
编组 21备份 2
Share
Report
Snoopdog
Snoopdog
·
2022-05-05
Like
Nasdaq Bear Market: 3 Growth Stocks Down 64% (or More) Just Begging to Be Bought
These beaten-down stocks are screaming buys following a peak decline of 23% in the Nasdaq.
Nasdaq Bear Market: 3 Growth Stocks Down 64% (or More) Just Begging to Be Bought
看
2.76K
回复
Comment
点赞
4
编组 21备份 2
Share
Report
Snoopdog
Snoopdog
·
2022-04-23
Like
Wall St Slumps as Weak Earnings, Rate Hike Clarity Spook Investors
* Healthcare stocks slump on HCA, Intuitive Surgical numbers* Big tech down ahead of earnings next w
Wall St Slumps as Weak Earnings, Rate Hike Clarity Spook Investors
看
2.41K
回复
Comment
点赞
6
编组 21备份 2
Share
Report
Snoopdog
Snoopdog
·
2022-04-15
Like
Sorry, this post has been deleted
看
2.34K
回复
Comment
点赞
5
编组 21备份 2
Share
Report
Snoopdog
Snoopdog
·
2022-04-14
Like
Why Is Ginkgo Bioworks (DNA) Stock Up Today?
Cell programming company Ginkgo Bioworks(NYSE:DNA) is in the green today on promising new collaborat
Why Is Ginkgo Bioworks (DNA) Stock Up Today?
看
2.81K
回复
Comment
点赞
5
编组 21备份 2
Share
Report
Snoopdog
Snoopdog
·
2022-04-11
Like
2 Growth Stocks With Monster Upside of at Least 145%, According to Wall Street
Some analysts are forecasting big gains for shareholders of these businesses.
2 Growth Stocks With Monster Upside of at Least 145%, According to Wall Street
看
2.66K
回复
Comment
点赞
5
编组 21备份 2
Share
Report
Snoopdog
Snoopdog
·
2022-04-10
Like
7 Financial Stocks Reporting Earnings the Week of April 11
JPMorgan Chase(JPM) — Largest U.S bank could take some hefty losses from exposure to Russia.BlackRoc
7 Financial Stocks Reporting Earnings the Week of April 11
看
2.41K
回复
Comment
点赞
7
编组 21备份 2
Share
Report
Snoopdog
Snoopdog
·
2022-04-07
Like pls
US STOCKS-Wall Street Ends Lower After Fed Minutes
Wall Street's main indexes fell on Wednesday, with steep declines in tech and other growth stocks, a
US STOCKS-Wall Street Ends Lower After Fed Minutes
看
2.59K
回复
Comment
点赞
3
编组 21备份 2
Share
Report
Snoopdog
Snoopdog
·
2022-04-06
Like
FDA Pulls Authorization for GSK-Vir's COVID Therapy as BA.2 Cases Rise
April 5 (Reuters) - The U.S. health regulator said on Tuesday GlaxoSmithKline and Vir Biotechnology'
FDA Pulls Authorization for GSK-Vir's COVID Therapy as BA.2 Cases Rise
看
1.88K
回复
Comment
点赞
2
编组 21备份 2
Share
Report
Snoopdog
Snoopdog
·
2022-04-05
Like
3 High-Yield Dividend Stocks to Buy in a Market Rebound
It could be a good time to lock in these high yields.
3 High-Yield Dividend Stocks to Buy in a Market Rebound
看
3.17K
回复
Comment
点赞
3
编组 21备份 2
Share
Report
Load more
Most Discussed
{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3567748507194894","uuid":"3567748507194894","gmtCreate":1604656153553,"gmtModify":1608630758352,"name":"Snoopdog","pinyin":"snoopdog","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/8620e2cb2714470a199bcb823c9be5ed","hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","hatId":"ca_profile_frame_DWr5S1","hatName":"","vip":1,"status":2,"fanSize":23,"headSize":452,"tweetSize":155,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.16","exceedPercentage":"93.10%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.16","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.85%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.04","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":217921133060160,"gmtCreate":1694238185747,"gmtModify":1694238191211,"author":{"id":"3567748507194894","authorId":"3567748507194894","name":"Snoopdog","avatar":"https://static.tigerbbs.com/8620e2cb2714470a199bcb823c9be5ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3567748507194894","authorIdStr":"3567748507194894"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/ABML\">$American Battery Technology Company(ABML)$ </a>Can't buy this stock on Tiger now :(","listText":"<a href=\"https://ttm.financial/S/ABML\">$American Battery Technology Company(ABML)$ </a>Can't buy this stock on Tiger now :(","text":"$American Battery Technology Company(ABML)$ Can't buy this stock on Tiger now :(","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/217921133060160","isVote":1,"tweetType":1,"viewCount":2134,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9068192681,"gmtCreate":1651729639009,"gmtModify":1676534958219,"author":{"id":"3567748507194894","authorId":"3567748507194894","name":"Snoopdog","avatar":"https://static.tigerbbs.com/8620e2cb2714470a199bcb823c9be5ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3567748507194894","authorIdStr":"3567748507194894"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9068192681","repostId":"2232025659","repostType":4,"repost":{"id":"2232025659","kind":"highlight","pubTimestamp":1651712452,"share":"https://ttm.financial/m/news/2232025659?lang=&edition=fundamental","pubTime":"2022-05-05 09:00","market":"us","language":"en","title":"Nasdaq Bear Market: 3 Growth Stocks Down 64% (or More) Just Begging to Be Bought","url":"https://stock-news.laohu8.com/highlight/detail?id=2232025659","media":"Motley Fool","summary":"These beaten-down stocks are screaming buys following a peak decline of 23% in the Nasdaq.","content":"<div>\n<p>Whether you're a new or tenured investor, the stock market has sent a clear message over the past four months that corrections are an inevitable part of the investing cycle.Since the year began, the ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/05/04/nasdaq-bear-market-3-growth-stocks-down-64-to-buy/\">Web Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq Bear Market: 3 Growth Stocks Down 64% (or More) Just Begging to Be Bought</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq Bear Market: 3 Growth Stocks Down 64% (or More) Just Begging to Be Bought\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-05 09:00 GMT+8 <a href=https://www.fool.com/investing/2022/05/04/nasdaq-bear-market-3-growth-stocks-down-64-to-buy/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Whether you're a new or tenured investor, the stock market has sent a clear message over the past four months that corrections are an inevitable part of the investing cycle.Since the year began, the ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/05/04/nasdaq-bear-market-3-growth-stocks-down-64-to-buy/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GTBIF":"Green Thumb Industries Inc.","SE":"Sea Ltd","ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2022/05/04/nasdaq-bear-market-3-growth-stocks-down-64-to-buy/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2232025659","content_text":"Whether you're a new or tenured investor, the stock market has sent a clear message over the past four months that corrections are an inevitable part of the investing cycle.Since the year began, the benchmark S&P 500 and iconic Dow Jones Industrial Average entered correction territory with respective declines of at least 10%. Things have been even worse for the growth-driven Nasdaq Composite, which has shed 23% since hitting its all-time closing high in November. This officially puts the Nasdaq in its first bear market since the pandemic meltdown in March 2020.Although big declines in the major indexes can be scary at times, history has shown that they're the perfect time to put your money to work. Every major index, including the Nasdaq Composite, eventually shrugs off each and every correction.What's more, growth stocks can be one of the smartest places to invest your money during a correction or bear market. A Bank of America/Merrill Lynch report that examined the performance of growth stocks and value stocks over 90 years (1926-2015) found that growth stocks outperformed during recessions and periods of economic weakness.The following three growth stocks are at least 64% below their all-time highs and are now begging to be bought at reduced levels.Sea Limited: Down 78% from its all-time highThe first growth stock that's taken an absolute beating as the Nasdaq has swooned is Singapore-based conglomerate Sea Limited. Shares of Sea skyrocketed tenfold in just an 18-month period during the pandemic, but have gone on to lose 78% of their value since peaking in October.Sea is facing a number of pressing questions as global inflation heats up and COVID-19 continues to wreak havoc on supply chains, especially in Asian markets. In particular, Wall Street had become accustomed to jaw-dropping sales growth over the past couple of years. Looking ahead, Sea's revenue growth is slated to slow a bit, with annual losses expected to continue for a few more years. When big market declines occur, valuation comes into focus, and companies with large annual losses, like Sea Limited, often take it on the chin.But there's another side to this story that should excite patient growth investors. Specifically, Sea has three rapidly growing segments that can all become serious cash flow generators.For the moment, the company's gaming division, known as Garena, is the only operating segment bringing in positive earnings before interest, taxes, depreciation, and amortization (EBITDA). Hit mobile game Free Fire helped lift the number of quarterly active users (QAUs) to 654 million as of the end of 2021. More importantly, 11.8% of these QAUs were paying to play Sea's games. The typical pay-to-play conversion ratio in mobile gaming is in the low single digits.There's also excitement for SeaMoney, the company's digital financial services segment. Although it's still relatively new, nearly 46 million QAUs were using SeaMoney products and services, such as digital wallets, in the fourth quarter. This is an intriguing segment considering that Sea operates in a number of emerging regions where access to basic banking services can be limited.Lastly, there's e-commerce platform Shopee, which has consistently been the most downloaded shopping app in Southeast Asia. Shopee has been picking up momentum in Brazil, too. During the fourth quarter, Shopee had $18.2 billion in gross merchandise value (GMV) traverse its network. That's more than the $10 billion in GMV recognized in all of 2018. If Sea can significantly improve e-commerce EBITDA into 2023, its share price could rebound in a big way.Green Thumb Industries: Down 64% from its all-time highA second growth stock that's been absolutely pulverized and is now begging to be bought is cannabis multi-state operator (MSO) Green Thumb Industries. Shares of Green Thumb have declined by 64% since hitting their intra-day high a little over a year ago.During the first quarter of 2021, marijuana stocks were all the rage. A Democrat-led Congress, coupled with President Joe Biden taking office, made it appear likely that federal legalization, or at the very least cannabis banking reform, would become a reality. However, with COVID-19 and geopolitical issues dominating lawmakers' time, no reforms have been passed on Capitol Hill. As a result, pot stocks like Green Thumb have been taken to the woodshed.But despite a lack of federal reforms, we've still witnessed three-quarters of all states legalize cannabis in some capacity. To add, 18 of these states have green-lit adult-use recreational consumption. The point is that individual state regulation is providing more than enough opportunity for well-funded MSOs to thrive.Green Thumb opened its 77th operating dispensary last month and generated retail sales from 14 states in 2021. Although it does have a presence in high-dollar markets like California, the company has wisely chosen to enter a number of limited-license markets. These are states that purposely limit how many cannabis dispensary licenses are issued in total, as well as to a single business. It's a way of promoting competition and ensuring that companies like Green Thumb have a fair shot to build up their brand(s) and garner a following.The one factor that really makes Green Thumb special is its product mix. Only around a third of the company's sales are derived from dried flower. The remainder comes from vape products, infused beverages, pre-rolls, edibles, and other derivatives. The key here is that derivatives sport higher price points and better margins. These higher margins have allowed Green Thumb to generate recurring profits while most other MSOs are still losing money.Considering that Green Thumb Industries is expected to continue growing its sales by 20% to 25% annually, its forward-year price-to-earnings ratio of 24 makes it a bargain.Etsy: Down 70% from its all-time highA third and final growth stock that's been battered by the Nasdaq bear market decline is specialty online retail platform Etsy. The former pandemic superstar has shed 70% of its value since hitting an all-time intra-day high five months ago.The biggest concerns for Etsy are historically high inflation and the growing prospect of a recession in the United States. The cost for virtually everything has soared, which threatens to reduce consumer spending. That would be bad news for Etsy, which relies on merchants to boost their ad spending over time.On the other hand, trying to time inevitable recessions in the U.S. economy is a fool's errand. History has shown that most recessions only last a few months or a couple of quarters. By comparison, periods of economic expansion are measured in years. Buying rapidly growing and innovative e-commerce players during periods of weakness and holding for years is probably going to be a smart move.Furthermore, Etsy brings a competitive advantage to the table that should allow it to stand out. Whereas most online retail platforms target volume, Etsy's merchants are usually smaller businesses that offer unique/customized products and services that enhance consumer engagement. There's not an online retail platform that offers engagement at scale quite like Etsy.Something else to excite long-term investors is Etsy's success in converting casual shoppers into habitual buyers. A habitual buyer is defined as a shopper who makes at least six purchases over a trailing-12-month period, with the aggregate value of those purchases hitting at least $200. Since the beginning of the pandemic, the number of habitual buyers has grown by 224%! These habitual buyers are the company's key to extracting more ad revenue out of the merchants on its platform.Even if the U.S. enters a recession -- U.S. first-quarter gross domestic product declined by 1.4% -- Etsy is well-positioned to deliver sustainable double-digit sales growth. Based on Wall Street's consensus profit forecast (which has proved fluid in recent weeks), a share of Etsy can be picked up for just 21 times forecast earnings in 2023. That's as inexpensive as this company has ever been.","news_type":1,"symbols_score_info":{"GTBIF":0.9,"SE":0.9,"ETSY":0.9}},"isVote":1,"tweetType":1,"viewCount":2760,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9085627337,"gmtCreate":1650692038099,"gmtModify":1676534778463,"author":{"id":"3567748507194894","authorId":"3567748507194894","name":"Snoopdog","avatar":"https://static.tigerbbs.com/8620e2cb2714470a199bcb823c9be5ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3567748507194894","authorIdStr":"3567748507194894"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9085627337","repostId":"2229641491","repostType":4,"repost":{"id":"2229641491","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1650668840,"share":"https://ttm.financial/m/news/2229641491?lang=&edition=fundamental","pubTime":"2022-04-23 07:07","market":"us","language":"en","title":"Wall St Slumps as Weak Earnings, Rate Hike Clarity Spook Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2229641491","media":"Reuters","summary":"* Healthcare stocks slump on HCA, Intuitive Surgical numbers* Big tech down ahead of earnings next w","content":"<html><head></head><body><p>* Healthcare stocks slump on HCA, Intuitive Surgical numbers</p><p>* Big tech down ahead of earnings next week</p><p>* Dow posts biggest one-day fall since Oct. 2020</p><p>* Weekly falls: Dow 1.9%, S&P 2.8%, Nasdaq 3.8%</p><p>* Indexes down on Friday: Dow 2.82%, S&P 2.77%, Nasdaq 2.55% </p><p>April 22 (Reuters) - Wall Street tumbled more than 2.5% on Friday, ensuring the three main benchmarks ended in negative territory for the week, as surprise earnings news and increased certainty around aggressive near-term interest rate rises took its toll on investors.</p><p>It was the third straight week of losses for both the S&P 500 and the Nasdaq, while the Dow Jones posted its fourth weekly decline in a row.</p><p>For the Dow, its 2.82% drop on Friday was its biggest one-day fall since October 2020.</p><p>Exaggerated trading swings have become more common recently, as traders adjust to new data points from earnings, as well as when rates will rise again. For the Nasdaq, Friday was the eighth session in April, out of 15 trading days this month, where the index either rose or fell by more than 2%.</p><p>"It's not very common, over the course of my time doing this job, for the market to move 2% in either direction and to think 'there's not too much to read into that'," said Craig Erlam, senior market analyst at OANDA.</p><p>"That's not normal, but that's just how things have been for such a long time now."</p><p>Concerns about risks from interest rate hikes continued to reverberate after Federal Reserve Chair Jerome Powell's hawkish pivot on Thursday, where he backed moving more quickly to combat inflation and said a 50-basis-point increase would be "on the table" when the Fed meets in May.</p><p>The idea of "front-end loading" the U.S. central bank's retreat from super-easy monetary policy, which Powell articulated support for on Thursday, has also forced traders to re-evaluate how aggressive subsequent rate rises would be.</p><p>The CBOE Volatility index, also known as Wall Street's fear gauge, jumped on Friday, ending at its highest level since mid-March.</p><p>Meanwhile, the latest earnings forecasts to jolt investors came from healthcare, with HCA Healthcare and Intuitive Surgical Inc the worst performers on the S&P 500.</p><p>HCA slumped 21.8% after reporting a downbeat profit view, while other hospital operators felt the contagion: Tenet Healthcare, Community Health Systems and Universal Health Services all tumbled between 14% and 17.9%.</p><p>Surgical robot maker Intuitive Surgical dropped 14.3% after warning of weaker demand from hospitals due to tighter finances.</p><p>All 11 major S&P 500 sectors were down, although the 3.6% slip by healthcare was outdone by materials, which was off 3.7%.</p><p>Materials was weighed down by Nucor Corp - down 8.3% after hitting a record high after posting earnings on Thursday - and Freeport-McMoRan Inc, which slipped 6.8% as investors fretted over how interest rate hikes would impact copper miners.</p><p>The Dow Jones Industrial Average fell 981.36 points, or 2.82%, to 33,811.4, the S&P 500 lost 121.88 points, or 2.77%, to 4,271.78 and the Nasdaq Composite dropped 335.36 points, or 2.55%, to 12,839.29.</p><p>For the week, the Dow dipped 1.9%, the S&P dropped 2.8%, and the Nasdaq declined 3.8%.</p><p>The prospect of a more hawkish Fed has led to a rocky start to the year for equities, with Friday's sell-off taking declines on both the S&P and Dow since the start of the year beyond 10%.</p><p>The trend is more pronounced in tech and growth shares whose valuations are more vulnerable to rising bond yields. The Nasdaq is down 17.9% in 2022.</p><p>Earnings are due next week for the four biggest U.S. companies by market capitalization: Apple, Microsoft , Amazon and Google parent Alphabet.</p><p>The quartet declined between 2.4% and 4.1% on Friday. Meta Platforms Inc, which also has results on deck for next week, dropped 2.1%, taking its losses in the last three days to 15.3%.</p><p>Investors are worried after streaming giant Netflix Inc's dismal earnings earlier this week sent shockwaves through big tech and stay-at-home darlings which benefited from pandemic factors such as lockdown measures.</p><p>The volume on U.S. exchanges was 11.66 billion shares, compared with the 11.67 billion average for the full session over the last 20 trading days.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St Slumps as Weak Earnings, Rate Hike Clarity Spook Investors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St Slumps as Weak Earnings, Rate Hike Clarity Spook Investors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-04-23 07:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>* Healthcare stocks slump on HCA, Intuitive Surgical numbers</p><p>* Big tech down ahead of earnings next week</p><p>* Dow posts biggest one-day fall since Oct. 2020</p><p>* Weekly falls: Dow 1.9%, S&P 2.8%, Nasdaq 3.8%</p><p>* Indexes down on Friday: Dow 2.82%, S&P 2.77%, Nasdaq 2.55% </p><p>April 22 (Reuters) - Wall Street tumbled more than 2.5% on Friday, ensuring the three main benchmarks ended in negative territory for the week, as surprise earnings news and increased certainty around aggressive near-term interest rate rises took its toll on investors.</p><p>It was the third straight week of losses for both the S&P 500 and the Nasdaq, while the Dow Jones posted its fourth weekly decline in a row.</p><p>For the Dow, its 2.82% drop on Friday was its biggest one-day fall since October 2020.</p><p>Exaggerated trading swings have become more common recently, as traders adjust to new data points from earnings, as well as when rates will rise again. For the Nasdaq, Friday was the eighth session in April, out of 15 trading days this month, where the index either rose or fell by more than 2%.</p><p>"It's not very common, over the course of my time doing this job, for the market to move 2% in either direction and to think 'there's not too much to read into that'," said Craig Erlam, senior market analyst at OANDA.</p><p>"That's not normal, but that's just how things have been for such a long time now."</p><p>Concerns about risks from interest rate hikes continued to reverberate after Federal Reserve Chair Jerome Powell's hawkish pivot on Thursday, where he backed moving more quickly to combat inflation and said a 50-basis-point increase would be "on the table" when the Fed meets in May.</p><p>The idea of "front-end loading" the U.S. central bank's retreat from super-easy monetary policy, which Powell articulated support for on Thursday, has also forced traders to re-evaluate how aggressive subsequent rate rises would be.</p><p>The CBOE Volatility index, also known as Wall Street's fear gauge, jumped on Friday, ending at its highest level since mid-March.</p><p>Meanwhile, the latest earnings forecasts to jolt investors came from healthcare, with HCA Healthcare and Intuitive Surgical Inc the worst performers on the S&P 500.</p><p>HCA slumped 21.8% after reporting a downbeat profit view, while other hospital operators felt the contagion: Tenet Healthcare, Community Health Systems and Universal Health Services all tumbled between 14% and 17.9%.</p><p>Surgical robot maker Intuitive Surgical dropped 14.3% after warning of weaker demand from hospitals due to tighter finances.</p><p>All 11 major S&P 500 sectors were down, although the 3.6% slip by healthcare was outdone by materials, which was off 3.7%.</p><p>Materials was weighed down by Nucor Corp - down 8.3% after hitting a record high after posting earnings on Thursday - and Freeport-McMoRan Inc, which slipped 6.8% as investors fretted over how interest rate hikes would impact copper miners.</p><p>The Dow Jones Industrial Average fell 981.36 points, or 2.82%, to 33,811.4, the S&P 500 lost 121.88 points, or 2.77%, to 4,271.78 and the Nasdaq Composite dropped 335.36 points, or 2.55%, to 12,839.29.</p><p>For the week, the Dow dipped 1.9%, the S&P dropped 2.8%, and the Nasdaq declined 3.8%.</p><p>The prospect of a more hawkish Fed has led to a rocky start to the year for equities, with Friday's sell-off taking declines on both the S&P and Dow since the start of the year beyond 10%.</p><p>The trend is more pronounced in tech and growth shares whose valuations are more vulnerable to rising bond yields. The Nasdaq is down 17.9% in 2022.</p><p>Earnings are due next week for the four biggest U.S. companies by market capitalization: Apple, Microsoft , Amazon and Google parent Alphabet.</p><p>The quartet declined between 2.4% and 4.1% on Friday. Meta Platforms Inc, which also has results on deck for next week, dropped 2.1%, taking its losses in the last three days to 15.3%.</p><p>Investors are worried after streaming giant Netflix Inc's dismal earnings earlier this week sent shockwaves through big tech and stay-at-home darlings which benefited from pandemic factors such as lockdown measures.</p><p>The volume on U.S. exchanges was 11.66 billion shares, compared with the 11.67 billion average for the full session over the last 20 trading days.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HCA":"HCA控股",".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","ISRG":"直觉外科公司"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2229641491","content_text":"* Healthcare stocks slump on HCA, Intuitive Surgical numbers* Big tech down ahead of earnings next week* Dow posts biggest one-day fall since Oct. 2020* Weekly falls: Dow 1.9%, S&P 2.8%, Nasdaq 3.8%* Indexes down on Friday: Dow 2.82%, S&P 2.77%, Nasdaq 2.55% April 22 (Reuters) - Wall Street tumbled more than 2.5% on Friday, ensuring the three main benchmarks ended in negative territory for the week, as surprise earnings news and increased certainty around aggressive near-term interest rate rises took its toll on investors.It was the third straight week of losses for both the S&P 500 and the Nasdaq, while the Dow Jones posted its fourth weekly decline in a row.For the Dow, its 2.82% drop on Friday was its biggest one-day fall since October 2020.Exaggerated trading swings have become more common recently, as traders adjust to new data points from earnings, as well as when rates will rise again. For the Nasdaq, Friday was the eighth session in April, out of 15 trading days this month, where the index either rose or fell by more than 2%.\"It's not very common, over the course of my time doing this job, for the market to move 2% in either direction and to think 'there's not too much to read into that',\" said Craig Erlam, senior market analyst at OANDA.\"That's not normal, but that's just how things have been for such a long time now.\"Concerns about risks from interest rate hikes continued to reverberate after Federal Reserve Chair Jerome Powell's hawkish pivot on Thursday, where he backed moving more quickly to combat inflation and said a 50-basis-point increase would be \"on the table\" when the Fed meets in May.The idea of \"front-end loading\" the U.S. central bank's retreat from super-easy monetary policy, which Powell articulated support for on Thursday, has also forced traders to re-evaluate how aggressive subsequent rate rises would be.The CBOE Volatility index, also known as Wall Street's fear gauge, jumped on Friday, ending at its highest level since mid-March.Meanwhile, the latest earnings forecasts to jolt investors came from healthcare, with HCA Healthcare and Intuitive Surgical Inc the worst performers on the S&P 500.HCA slumped 21.8% after reporting a downbeat profit view, while other hospital operators felt the contagion: Tenet Healthcare, Community Health Systems and Universal Health Services all tumbled between 14% and 17.9%.Surgical robot maker Intuitive Surgical dropped 14.3% after warning of weaker demand from hospitals due to tighter finances.All 11 major S&P 500 sectors were down, although the 3.6% slip by healthcare was outdone by materials, which was off 3.7%.Materials was weighed down by Nucor Corp - down 8.3% after hitting a record high after posting earnings on Thursday - and Freeport-McMoRan Inc, which slipped 6.8% as investors fretted over how interest rate hikes would impact copper miners.The Dow Jones Industrial Average fell 981.36 points, or 2.82%, to 33,811.4, the S&P 500 lost 121.88 points, or 2.77%, to 4,271.78 and the Nasdaq Composite dropped 335.36 points, or 2.55%, to 12,839.29.For the week, the Dow dipped 1.9%, the S&P dropped 2.8%, and the Nasdaq declined 3.8%.The prospect of a more hawkish Fed has led to a rocky start to the year for equities, with Friday's sell-off taking declines on both the S&P and Dow since the start of the year beyond 10%.The trend is more pronounced in tech and growth shares whose valuations are more vulnerable to rising bond yields. The Nasdaq is down 17.9% in 2022.Earnings are due next week for the four biggest U.S. companies by market capitalization: Apple, Microsoft , Amazon and Google parent Alphabet.The quartet declined between 2.4% and 4.1% on Friday. Meta Platforms Inc, which also has results on deck for next week, dropped 2.1%, taking its losses in the last three days to 15.3%.Investors are worried after streaming giant Netflix Inc's dismal earnings earlier this week sent shockwaves through big tech and stay-at-home darlings which benefited from pandemic factors such as lockdown measures.The volume on U.S. exchanges was 11.66 billion shares, compared with the 11.67 billion average for the full session over the last 20 trading days.","news_type":1,"symbols_score_info":{"ISRG":0.9,".IXIC":0.9,".DJI":0.9,".SPX":0.9,"HCA":0.9}},"isVote":1,"tweetType":1,"viewCount":2412,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9089741333,"gmtCreate":1650038077131,"gmtModify":1676534634232,"author":{"id":"3567748507194894","authorId":"3567748507194894","name":"Snoopdog","avatar":"https://static.tigerbbs.com/8620e2cb2714470a199bcb823c9be5ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3567748507194894","authorIdStr":"3567748507194894"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9089741333","repostId":"1137462158","repostType":4,"isVote":1,"tweetType":1,"viewCount":2336,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9080426831,"gmtCreate":1649907730665,"gmtModify":1676534604774,"author":{"id":"3567748507194894","authorId":"3567748507194894","name":"Snoopdog","avatar":"https://static.tigerbbs.com/8620e2cb2714470a199bcb823c9be5ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3567748507194894","authorIdStr":"3567748507194894"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9080426831","repostId":"1148192262","repostType":4,"repost":{"id":"1148192262","kind":"news","pubTimestamp":1649906844,"share":"https://ttm.financial/m/news/1148192262?lang=&edition=fundamental","pubTime":"2022-04-14 11:27","market":"us","language":"en","title":"Why Is Ginkgo Bioworks (DNA) Stock Up Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1148192262","media":"InvestorPlace","summary":"Cell programming company Ginkgo Bioworks(NYSE:DNA) is in the green today on promising new collaborat","content":"<div>\n<p>Cell programming company Ginkgo Bioworks(NYSE:DNA) is in the green today on promising new collaboration announcements. DNA stock is up more than 11% today as investors seem pleased by the news.So, ...</p>\n\n<a href=\"https://investorplace.com/2022/04/why-is-ginkgo-bioworks-dna-stock-up-today/\">Web Link</a>\n\n</div>\n","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Is Ginkgo Bioworks (DNA) Stock Up Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Is Ginkgo Bioworks (DNA) Stock Up Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-14 11:27 GMT+8 <a href=https://investorplace.com/2022/04/why-is-ginkgo-bioworks-dna-stock-up-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cell programming company Ginkgo Bioworks(NYSE:DNA) is in the green today on promising new collaboration announcements. DNA stock is up more than 11% today as investors seem pleased by the news.So, ...</p>\n\n<a href=\"https://investorplace.com/2022/04/why-is-ginkgo-bioworks-dna-stock-up-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/04/why-is-ginkgo-bioworks-dna-stock-up-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148192262","content_text":"Cell programming company Ginkgo Bioworks(NYSE:DNA) is in the green today on promising new collaboration announcements. DNA stock is up more than 11% today as investors seem pleased by the news.So, what do you need to know about Ginkgo lately?Well, on Monday Ginkgo announced the launch of BiomEdit, a new microbiome company. As per the announcement, the company is expected to “discover, develop and introduce novel probiotics, bioactive molecules, engineered microbial medicines and microbial monitoring services for animal health.”The project is a collaboration between Ginkgo and Elanco(NYSE:ELAN), a global animal health company. BiomEdit will likely end up creating its own line of products intended to enhance animal health. This includes “medicated feed ingredients, nutritional health and therapeutics for livestock and pet species, as well as biosecurity technology for animal disease monitoring.”However, this isn’t the only news out of Ginkgo lately.DNA Stock Soars on New CollaborationsMonday’s partnership announcement with Elanco was quickly joined by another collaboration yesterday. Indeed, Ginkgo is collaborating with Persephone Biosciences to develop a new therapeutic treatment based on the Bacteroides bacterial genus. The announcement delved into the relevance of the treatment:“Bacteroides species are among the most common members of the microbiota of animals, especially in the gastrointestinal tract, and are likely a useful tool for stable and long-term delivery of microbial medicines … Persephone is pioneering the use of synthetic biology for the development of microbial products that impact patient and infant health, which requires the ability to engineer Bacteroides strains for therapeutic applications.”Persephone, an early-stage biotech company, specializes in synthetic biology. The partnership should enhance and accelerate the development of Persephone’s treatments with Gingko’s engineering capabilities and scale.Clearly, Ginkgo investors have plenty to be hopeful for given the company’s recent deals.","news_type":1,"symbols_score_info":{"DNA":0.9}},"isVote":1,"tweetType":1,"viewCount":2811,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9014647667,"gmtCreate":1649657224575,"gmtModify":1676534545984,"author":{"id":"3567748507194894","authorId":"3567748507194894","name":"Snoopdog","avatar":"https://static.tigerbbs.com/8620e2cb2714470a199bcb823c9be5ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3567748507194894","authorIdStr":"3567748507194894"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9014647667","repostId":"2226250390","repostType":4,"repost":{"id":"2226250390","kind":"highlight","pubTimestamp":1649636151,"share":"https://ttm.financial/m/news/2226250390?lang=&edition=fundamental","pubTime":"2022-04-11 08:15","market":"us","language":"en","title":"2 Growth Stocks With Monster Upside of at Least 145%, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2226250390","media":"Motley Fool","summary":"Some analysts are forecasting big gains for shareholders of these businesses.","content":"<div>\n<p>The growth-heavy Nasdaq Composite has dipped in and out of bear market territory this year. Many investors are worried that the combination of rampant inflation, geopolitical conflict, and rising ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/04/10/growth-stocks-upside-145-according-to-wall-street/\">Web Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Growth Stocks With Monster Upside of at Least 145%, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Growth Stocks With Monster Upside of at Least 145%, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-11 08:15 GMT+8 <a href=https://www.fool.com/investing/2022/04/10/growth-stocks-upside-145-according-to-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The growth-heavy Nasdaq Composite has dipped in and out of bear market territory this year. Many investors are worried that the combination of rampant inflation, geopolitical conflict, and rising ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/04/10/growth-stocks-upside-145-according-to-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COIN":"Coinbase Global, Inc.","ROKU":"Roku Inc"},"source_url":"https://www.fool.com/investing/2022/04/10/growth-stocks-upside-145-according-to-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2226250390","content_text":"The growth-heavy Nasdaq Composite has dipped in and out of bear market territory this year. Many investors are worried that the combination of rampant inflation, geopolitical conflict, and rising interest rates will cause a significant pullback in spending. In turn, that would negatively affect corporate revenue and profits. So to minimize near-term risk, many investors have been selling stocks, especially richly-valued growth stocks.However, some analysts think that selling is overdone. For instance, Daniel Kurnos of investment banking firm Benchmark has a price target of $305 on Roku, implying 166% upside from its current price. Similarly, JMP Securities analyst Devin Ryan has a price target of $394 on Coinbase Global, implying 145% upside from its current price.Given those analysts' bullish outlooks, let's take a closer look at both stocks.Image source: Getty Images.1. RokuFor millions of people, Roku has become the gateway to streaming entertainment. In fact, its platform powered nearly 32% of \"big screen\" (or television) viewing time last year, up 70 basis points from 2020. Meanwhile, second-place rival Amazon Fire TV captured just 16.5% market share, down 270 basis points from the prior year. Put another way, Roku is becoming more dominant, while its closest competitor is losing ground.What's driving that success? Management points to its operating system. Roku OS is the only operating system purpose-built for TV. Competing solutions like Amazon's Fire OS are modified versions of a mobile operating system. Roku believes its purpose-built approach creates a better viewing experience. CEO Anthony Wood recently said, \"If you look at the history of computing platforms [...] purpose-built operating systems traditionally have always won in terms of market share.\"In addition, Roku has also been investing in its ad-supported streaming service, The Roku Channel. It released more than 50 original titles in 2021, including its first feature-length film. With that strategy, Roku aims to drive viewer engagement (and ad spend) by further differentiating its platform. The early results are promising. In 2021, half of the top 10 titles on The Roku Channel were Roku Originals, and The Roku Channel itself ranked among the top five channels on the platform in the third and fourth quarters.In turn, monetized ad impressions on Roku's platform nearly doubled in 2021, which translated into strong financial results. Revenue soared 55% to $2.8 billion last year, and the company generated $188 million in free cash flow, up nearly threefold from $66 million in 2020. But shareholders have good reason to believe Roku can maintain that momentum.For many people, streaming media is already the go-to option for home entertainment, but ad budgets are still playing catch-up. Case in point: Connected TV (CTV) ad spend totaled $13.4 billion in the U.S. last year, but marketers spent $65.9 billion, nearly five times as much, on linear TV ads, according to eMarketer. As ad budgets continue to follow viewers to CTV, Roku should benefit. From that perspective, this growth stock could certainly generate 166% returns in the near term, but Roku is better viewed as a long-term investment.2. Coinbase GlobalCoinbase is the largest U.S. cryptocurrency exchange. Its platform offers a range of services to retail traders and institutional investors, helping them securely buy, sell, spend, store, and stake crypto assets. The company has achieved significant scale as it currently holds a market-leading 11.5% of all crypto assets on its platform. That creates a deep pool of liquidity that Coinbase can use to fund growth initiatives like its soon-to-launch non-fungible token (NFT) marketplace.More broadly, the Coinbase brand inspires trust, and for many investors, it has become synonymous with cryptocurrency. That has led to strong financial results. In 2021, Coinbase saw its number of monthly transacting users grow fourfold to 11.4 million, and trading volume rose more than eightfold to $1.7 trillion. In turn, revenue skyrocketed 514% to $7.8 billion, and GAAP earnings grew more than tenfold to $14.50 per diluted share.Looking ahead, Coinbase is well positioned to maintain that momentum. Cryptocurrencies are nothing if not volatile, and the company benefits from that volatility. Most of its revenue is generated through transaction fees. In other words, the more people trade, the more money Coinbase makes. And the crypto market has crashed twice in the past 12 months, meaning a lot of cryptocurrency was being bought and sold.In addition, Coinbase CEO Brian Armstrong believes the coming NFT marketplace could be bigger than its current cryptocurrency business. From that perspective, the analyst's price target of $394 seems entirely plausible. That being said, even if Coinbase stock continues to underperform in the short term, it still looks like a smart choice for patient investors, especially if you believe in the future of the crypto economy.","news_type":1,"symbols_score_info":{"COIN":0.9,"ROKU":0.9}},"isVote":1,"tweetType":1,"viewCount":2658,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9014995438,"gmtCreate":1649578034680,"gmtModify":1676534533620,"author":{"id":"3567748507194894","authorId":"3567748507194894","name":"Snoopdog","avatar":"https://static.tigerbbs.com/8620e2cb2714470a199bcb823c9be5ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3567748507194894","authorIdStr":"3567748507194894"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9014995438","repostId":"1100700023","repostType":4,"repost":{"id":"1100700023","kind":"news","pubTimestamp":1649556005,"share":"https://ttm.financial/m/news/1100700023?lang=&edition=fundamental","pubTime":"2022-04-10 10:00","market":"us","language":"en","title":"7 Financial Stocks Reporting Earnings the Week of April 11","url":"https://stock-news.laohu8.com/highlight/detail?id=1100700023","media":"InvestorPlace","summary":"JPMorgan Chase(JPM) — Largest U.S bank could take some hefty losses from exposure to Russia.BlackRoc","content":"<div>\n<p>JPMorgan Chase(JPM) — Largest U.S bank could take some hefty losses from exposure to Russia.BlackRock(BLK) — World’s largest asset manager, volatility may sap their earnings.Wells Fargo(WFC) — Major ...</p>\n\n<a href=\"https://investorplace.com/2022/04/7-financial-stocks-reporting-earnings-the-week-of-april-11/\">Web Link</a>\n\n</div>\n","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Financial Stocks Reporting Earnings the Week of April 11</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Financial Stocks Reporting Earnings the Week of April 11\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-10 10:00 GMT+8 <a href=https://investorplace.com/2022/04/7-financial-stocks-reporting-earnings-the-week-of-april-11/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>JPMorgan Chase(JPM) — Largest U.S bank could take some hefty losses from exposure to Russia.BlackRock(BLK) — World’s largest asset manager, volatility may sap their earnings.Wells Fargo(WFC) — Major ...</p>\n\n<a href=\"https://investorplace.com/2022/04/7-financial-stocks-reporting-earnings-the-week-of-april-11/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"C":"花旗","BLK":"贝莱德","JPM":"摩根大通","STT":"道富银行","WFC":"富国银行","MS":"摩根士丹利","GS":"高盛"},"source_url":"https://investorplace.com/2022/04/7-financial-stocks-reporting-earnings-the-week-of-april-11/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100700023","content_text":"JPMorgan Chase(JPM) — Largest U.S bank could take some hefty losses from exposure to Russia.BlackRock(BLK) — World’s largest asset manager, volatility may sap their earnings.Wells Fargo(WFC) — Major bank that’s still down this year but has been aggressively repurchasing its stock.Morgan Stanley(MS) — Has weathered the current volatility better than others and could see a bounce after earnings.Goldman Sachs(GS) — A well established money maker that’s currently expanding it’s retail banking business.Citigroup(C) — International exposure puts this bank’s earnings at risk.State Street(STT) — Regional bank that might surprise shareholders.Earnings for the first quarter of the year kick-off next week with reports from the largest U.S. banks and fund managers. The lenders could use some good news.The Dow Jones U.S. Banks Index is down 20% since mid-January amid ongoing market volatility and uncertainty related to inflation and the war in Ukraine. The Federal Reserve (Fed) has begun to raise interest rates and that is normally a positive catalyst for banks as a higher rate environment enables them to charge more interest on their various loans. However, concerns about the pace and aggressiveness of the Fed’s tightening cycle has led bank stocks to fall in recent months rather than rise. A strong parade of earnings in the coming week could help to reverse the downward trend.JPMorgan Chase (JPM)The week begins with a print from JPMorgan Chase(NYSE:JPM), the largest U.S. bank with nearly $4 trillion of assets under management. The lender’s stock could use a boost that a solid earnings beat would provide. Year to date, JPM stock is down 20% at $129.23 a share. In addition to the market downturn, the share price has taken a hit from questions about the bank’s push into retail banking in England. Plans to spend $15 billion this year on “new projects,” mostly new technologies are raising concerns as well.In terms of its Q1 earnings, analysts are calling for JPMorgan Chase to report earnings per share (EPS) of $2.69 on revenues of $31.08 billion. A beat to the upside for the quarter ended March 31 might be hard to achieve. JPMorgan Chase chief executive officer (CEO) Jamie Dimon recently warned that the bank could lose $1 billion on its exposure to Russia, which has been heavily sanctioned since it invaded Ukraine in late February.BlackRock (BLK)The world’s largest asset manager with $10 trillion currently under management, BlackRock’s(NYSE:BLK) stock has also taken a drubbing this year, down 19% since January at $739.17 per share. The asset manager recently made headlines for saying that stock picking matters more than ever in the current market that is rife with volatility. Inflation, elevated energy prices, aggressive central bank tightening, war in Europe, and supply chain constraints are likely to continue to wreak havoc in markets, says BlackRock.BlackRock CEO Larry Fink also made news in recent weeks after issuing his annual letter to shareholders in which he said Russia’s invasion of Ukraine is reversing the norms of globalization that were established after World War II. Like most U.S.-based financial institutions, BlackRock has suspended the purchase of any Russian securities in its actively managed and index portfolios. Wall Street is forecasting that BlackRock will report EPS of $9.08 on revenues of $4.86 billion when it announces its Q1 numbers.Wells Fargo (WFC)Shares of Wells Fargo(NYSE:WFC) are also down on the year, though not as much as most other bank stocks. So far in 2022, WFC stock is down 8% to $46.85 a share. A strong earnings report for the fourth and final quarter of 2021 has helped Wells Fargo weather the current market volatility better than most other financial institutions.Does Wells Fargo have another strong quarter to reveal? The lenders Q4 results were helped by an $875 million reserve release that the bank had set aside to safeguard against potential loan losses during the pandemic. Wells Fargo also continues to aggressively repurchase its own stock. In last year’s fourth quarter, it bought back 139.7 million of its shares worth approximately $7 billion. Analysts are calling for Wells Fargo to report EPS of 80 cents on revenues of $17.79 billion next week.Morgan Stanley (MS)Investment bank Morgan Stanley(NYSE:MS) has been more pessimistic than most financial institutions when it comes to the outlook for the stock market. Morgan Stanley’s lead analyst, Mike Wilson, recently called for a correction and decline of 13% in U.S. equity markets between now and September of this year. Wilson has also issued repeated warnings about risks to European stocks spreading globally. Morgan Stanley’s most pessimistic outlook came as U.S. equities were rallying at the end of March.For its part, Morgan Stanley’s stock has declined in tandem with shares of other lenders. Year to date, MS stock is down 18% to $82.01 a share. In early February, the share price was floating around $110. If Morgan Stanley’s Wilson is correct, the pain for bank stocks is likely to worsen before it improves. We’ll see if Morgan Stanley’s earnings can give the stock a bounce. Analysts have forecast that the investment bank will announce EPS of $34.25 on revenues of $288.99 million.Goldman Sachs (GS)The money minting machine that is Goldman Sachs(NYSE:GS) also reports earnings next week. And the leading Wall Street investment bank has a way of making money in even the most challenging conditions. Year to date GS stock is also down 20% to $312.36 a share. Most analysts are singling out Goldman Sachs as a buy the dip opportunity given its strong earnings track record and growth potential. Morgan Stanley recently placed a $418 price target on the stock, implying a 34% upside from current levels.Goldman Sachs continues to push into retail banking, which it hopes will complement its commercial loan and deals units. A leader in mergers and acquisitions as well as initial public offerings, the bank’s retail banking unit, branded Marcus, still has a ways to go to catch-up. However, the investment bank is also pushing into consumer loans, offering home equity lines of credit and other products. Wall Street has forecast that Goldman Sachs will report EPS of $9.06on revenues of $12.07 billion for Q1 2022.Citigroup (C)Citigroup(NYSE:C) is one of the most international of the big U.S. banks with operations in markets all over the world. While that is normally a good thing, it could be problematic this year given that war is raging in Europe and countries everywhere are grappling with inflation rates not seen since the 1980s. The lender has been pulling out of select foreign markets lately, recently announcing that it is selling its Indian retail business for $1.6 billion.As with other U.S. lenders, Citigroup’sexposure to Russia could impact its balance sheet in coming quarters. Russia is an especially acute issue for Citigroup as it has the most extensive operations in that country among American banks. Citigroup announced plans last April to sell its Russian consumer division, and it recently accelerated its timetable for getting out of the country. We’ll get an idea of how Citi’s exposure to Russia is impacting it when the bank issues its Q1 numbers. Analysts expect Citigroup will announce EPS of $1.63 on revenues of $18.29 billion.State Street (STT)Lastly, we’ll hear from Boston-based State Street(NYSE:STT), which is more of a regional than national bank. Founded in 1792, State Street is the second oldest continually operating bank in the U.S. Year to date, STT stock is down, although not as much as the larger institutions that it competes against. So far in 2022, State Street stock is down 9% at $84.42 per share. The stock has been essentially flat over the past year. Despite the poor showing, many analysts remain bullish on State Street stock, noting its attractive dividend yield of 2.74%, which is good for 57 cents a quarter.Analysts are looking for State Street to report EPS of $1.48 on revenues of $3.06 billion next week. State Street has received several upgraded analyst ratings in recent weeks, along with a few downgrades. However, most are placing an “overweight” rating on the shares and noting that the bank should perform well going forward in a high interest rate environment. The median price target on STT stock is $112, suggesting 35% upside from the stock’s current price.","news_type":1,"symbols_score_info":{"C":0.9,"STT":0.9,"WFC":0.9,"BLK":0.9,"JPM":0.9,"MS":0.9,"GS":0.9}},"isVote":1,"tweetType":1,"viewCount":2407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9012886040,"gmtCreate":1649304160437,"gmtModify":1676534489068,"author":{"id":"3567748507194894","authorId":"3567748507194894","name":"Snoopdog","avatar":"https://static.tigerbbs.com/8620e2cb2714470a199bcb823c9be5ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3567748507194894","authorIdStr":"3567748507194894"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9012886040","repostId":"2225561217","repostType":4,"repost":{"id":"2225561217","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1649286510,"share":"https://ttm.financial/m/news/2225561217?lang=&edition=fundamental","pubTime":"2022-04-07 07:08","market":"us","language":"en","title":"US STOCKS-Wall Street Ends Lower After Fed Minutes","url":"https://stock-news.laohu8.com/highlight/detail?id=2225561217","media":"Reuters","summary":"Wall Street's main indexes fell on Wednesday, with steep declines in tech and other growth stocks, a","content":"<html><head></head><body><p>Wall Street's main indexes fell on Wednesday, with steep declines in tech and other growth stocks, after minutes from the Federal Reserve's March meeting sharpened investors' focus on the U.S. central bank's plans to fight inflation.</p><p>The tech-heavy Nasdaq logged a decline of over 2% for a second straight day.</p><p>Minutes of the Fed's March 15-16 meeting showed policymakers rallying around plans to cut the central bank's massive balance sheet as soon as next month.</p><p>Wall Street's main indexes already had been solidly lower ahead of the minutes' release, building on declines from a day earlier when Fed Governor Lael Brainard's comments raised concerns about more aggressive Fed action to fight inflation.</p><p>"The Fed is determined to rein in inflation, and we just hope and pray that there will there will be a soft landing of the economy and not a hard landing that sends us into a recession," said Tim Ghriskey, senior portfolio strategist at Ingalls & Snyder.</p><p>The Dow Jones Industrial Average fell 144.67 points, or 0.42%, to 34,496.51, the S&P 500 lost 43.97 points, or 0.97%, to 4,481.15 and the Nasdaq Composite dropped 315.35 points, or 2.22%, to 13,888.82.</p><p>The technology and consumer discretionary</p><p>sectors both fell about 2.6%, while the S&P 500 growth index dropped about 2%.</p><p>Defensive sectors gained, led by a 2% rise for utilities and a 1.6% increase for healthcare and real estate.</p><p>Wall Street's indexes already had been down sharply for a second straight day before the closely watched minutes, as investors continued to digest Brainard's remarks from Tuesday.</p><p>Brainard said she expected a combination of interest rate increases and a rapid balance sheet runoff to bring U.S. monetary policy to a "more neutral position" later this year.</p><p>"She is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the more dovish members of the FOMC and so for her to come out as aggressively in stamping out inflation pressures with really more aggressive rate tightening and policies, I think that took the market off guard a little bit and I think you are seeing that continue today," said Anthony Saglimbene, global market strategist at Ameriprise.</p><p>The prospect of a more hawkish Fed led to a rocky start to the year for equities, and in particular tech and growth shares whose valuations are more vulnerable to higher bond yields. The Ukraine crisis has added to concerns, particularly about worsening inflation as commodity prices spike.</p><p>In company news, JetBlue Airways shares fell 8.7% as it mounted a vigorous defense of its unsolicited $3.6 billion bid to acquire ultra-low-cost carrier <a href=\"https://laohu8.com/S/SAVE\">Spirit Airlines</a>.</p><p>Declining issues outnumbered advancers on the NYSE by a 2.76-to-1 ratio; on Nasdaq, a 2.56-to-1 ratio favored decliners.</p><p>The S&P 500 posted 41 new 52-week highs and 22 new lows; the Nasdaq Composite recorded 41 new highs and 202 new lows.</p><p>About 12.6 billion shares changed hands in U.S. exchanges, compared with the 13 billion daily average over the last 20 sessions.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US STOCKS-Wall Street Ends Lower After Fed Minutes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS STOCKS-Wall Street Ends Lower After Fed Minutes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-04-07 07:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Wall Street's main indexes fell on Wednesday, with steep declines in tech and other growth stocks, after minutes from the Federal Reserve's March meeting sharpened investors' focus on the U.S. central bank's plans to fight inflation.</p><p>The tech-heavy Nasdaq logged a decline of over 2% for a second straight day.</p><p>Minutes of the Fed's March 15-16 meeting showed policymakers rallying around plans to cut the central bank's massive balance sheet as soon as next month.</p><p>Wall Street's main indexes already had been solidly lower ahead of the minutes' release, building on declines from a day earlier when Fed Governor Lael Brainard's comments raised concerns about more aggressive Fed action to fight inflation.</p><p>"The Fed is determined to rein in inflation, and we just hope and pray that there will there will be a soft landing of the economy and not a hard landing that sends us into a recession," said Tim Ghriskey, senior portfolio strategist at Ingalls & Snyder.</p><p>The Dow Jones Industrial Average fell 144.67 points, or 0.42%, to 34,496.51, the S&P 500 lost 43.97 points, or 0.97%, to 4,481.15 and the Nasdaq Composite dropped 315.35 points, or 2.22%, to 13,888.82.</p><p>The technology and consumer discretionary</p><p>sectors both fell about 2.6%, while the S&P 500 growth index dropped about 2%.</p><p>Defensive sectors gained, led by a 2% rise for utilities and a 1.6% increase for healthcare and real estate.</p><p>Wall Street's indexes already had been down sharply for a second straight day before the closely watched minutes, as investors continued to digest Brainard's remarks from Tuesday.</p><p>Brainard said she expected a combination of interest rate increases and a rapid balance sheet runoff to bring U.S. monetary policy to a "more neutral position" later this year.</p><p>"She is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the more dovish members of the FOMC and so for her to come out as aggressively in stamping out inflation pressures with really more aggressive rate tightening and policies, I think that took the market off guard a little bit and I think you are seeing that continue today," said Anthony Saglimbene, global market strategist at Ameriprise.</p><p>The prospect of a more hawkish Fed led to a rocky start to the year for equities, and in particular tech and growth shares whose valuations are more vulnerable to higher bond yields. The Ukraine crisis has added to concerns, particularly about worsening inflation as commodity prices spike.</p><p>In company news, JetBlue Airways shares fell 8.7% as it mounted a vigorous defense of its unsolicited $3.6 billion bid to acquire ultra-low-cost carrier <a href=\"https://laohu8.com/S/SAVE\">Spirit Airlines</a>.</p><p>Declining issues outnumbered advancers on the NYSE by a 2.76-to-1 ratio; on Nasdaq, a 2.56-to-1 ratio favored decliners.</p><p>The S&P 500 posted 41 new 52-week highs and 22 new lows; the Nasdaq Composite recorded 41 new highs and 202 new lows.</p><p>About 12.6 billion shares changed hands in U.S. exchanges, compared with the 13 billion daily average over the last 20 sessions.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","TQQQ":"纳指三倍做多ETF",".SPX":"S&P 500 Index","PSQ":"做空纳斯达克100指数ETF-ProShares","BK4504":"桥水持仓","QQQ":"纳指100ETF","SQQQ":"纳指三倍做空ETF","SAVE":"Spirit Airlines","BK4559":"巴菲特持仓","BK4008":"航空公司","BK4550":"红杉资本持仓","OEF":"标普100指数ETF-iShares","SPXU":"三倍做空标普500ETF-ProShares","IVV":"标普500ETF-iShares","SH":"做空标普500-Proshares","BK4581":"高盛持仓","SSO":"2倍做多标普500ETF-ProShares","QLD":"2倍做多纳斯达克100指数ETF-ProShares","JBLU":"捷蓝航空","DJX":"1/100道琼斯","OEX":"标普100","DXD":"两倍做空道琼30指数ETF-ProShares","SDOW":"三倍做空道指30ETF-ProShares","SPY":"标普500ETF","DDM":"2倍做多道指ETF-ProShares","UDOW":"三倍做多道指30ETF-ProShares","UPRO":"三倍做多标普500ETF-ProShares","QID":"两倍做空纳斯达克指数ETF-ProShares","BK4500":"航空公司","BK4534":"瑞士信贷持仓","SDS":"两倍做空标普500 ETF-ProShares",".DJI":"道琼斯","DOG":"道指ETF-ProShares做空",".IXIC":"NASDAQ Composite"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2225561217","content_text":"Wall Street's main indexes fell on Wednesday, with steep declines in tech and other growth stocks, after minutes from the Federal Reserve's March meeting sharpened investors' focus on the U.S. central bank's plans to fight inflation.The tech-heavy Nasdaq logged a decline of over 2% for a second straight day.Minutes of the Fed's March 15-16 meeting showed policymakers rallying around plans to cut the central bank's massive balance sheet as soon as next month.Wall Street's main indexes already had been solidly lower ahead of the minutes' release, building on declines from a day earlier when Fed Governor Lael Brainard's comments raised concerns about more aggressive Fed action to fight inflation.\"The Fed is determined to rein in inflation, and we just hope and pray that there will there will be a soft landing of the economy and not a hard landing that sends us into a recession,\" said Tim Ghriskey, senior portfolio strategist at Ingalls & Snyder.The Dow Jones Industrial Average fell 144.67 points, or 0.42%, to 34,496.51, the S&P 500 lost 43.97 points, or 0.97%, to 4,481.15 and the Nasdaq Composite dropped 315.35 points, or 2.22%, to 13,888.82.The technology and consumer discretionarysectors both fell about 2.6%, while the S&P 500 growth index dropped about 2%.Defensive sectors gained, led by a 2% rise for utilities and a 1.6% increase for healthcare and real estate.Wall Street's indexes already had been down sharply for a second straight day before the closely watched minutes, as investors continued to digest Brainard's remarks from Tuesday.Brainard said she expected a combination of interest rate increases and a rapid balance sheet runoff to bring U.S. monetary policy to a \"more neutral position\" later this year.\"She is one of the more dovish members of the FOMC and so for her to come out as aggressively in stamping out inflation pressures with really more aggressive rate tightening and policies, I think that took the market off guard a little bit and I think you are seeing that continue today,\" said Anthony Saglimbene, global market strategist at Ameriprise.The prospect of a more hawkish Fed led to a rocky start to the year for equities, and in particular tech and growth shares whose valuations are more vulnerable to higher bond yields. The Ukraine crisis has added to concerns, particularly about worsening inflation as commodity prices spike.In company news, JetBlue Airways shares fell 8.7% as it mounted a vigorous defense of its unsolicited $3.6 billion bid to acquire ultra-low-cost carrier Spirit Airlines.Declining issues outnumbered advancers on the NYSE by a 2.76-to-1 ratio; on Nasdaq, a 2.56-to-1 ratio favored decliners.The S&P 500 posted 41 new 52-week highs and 22 new lows; the Nasdaq Composite recorded 41 new highs and 202 new lows.About 12.6 billion shares changed hands in U.S. exchanges, compared with the 13 billion daily average over the last 20 sessions.","news_type":1,"symbols_score_info":{"161125":0.6,"513500":0.6,"OEX":0.6,"DOG":0.6,"SDS":0.6,"SAVE":0.9,"TQQQ":0.6,"DJX":0.6,".IXIC":0.9,"SSO":0.6,"UPRO":0.6,".DJI":0.9,"SPXU":0.6,"ESmain":0.6,"QLD":0.6,"IVV":0.6,"QQQ":0.6,"DXD":0.6,"SDOW":0.6,"DDM":0.6,"SPY":0.66,"NQmain":0.6,"QID":0.6,"SH":0.6,"MNQmain":0.6,"SQQQ":0.6,"UDOW":0.6,"JBLU":0.9,".SPX":0.9,"PSQ":0.6,"OEF":0.6}},"isVote":1,"tweetType":1,"viewCount":2590,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9016411714,"gmtCreate":1649217457243,"gmtModify":1676534472605,"author":{"id":"3567748507194894","authorId":"3567748507194894","name":"Snoopdog","avatar":"https://static.tigerbbs.com/8620e2cb2714470a199bcb823c9be5ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3567748507194894","authorIdStr":"3567748507194894"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9016411714","repostId":"1191934359","repostType":4,"repost":{"id":"1191934359","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1649216460,"share":"https://ttm.financial/m/news/1191934359?lang=&edition=fundamental","pubTime":"2022-04-06 11:41","market":"us","language":"en","title":"FDA Pulls Authorization for GSK-Vir's COVID Therapy as BA.2 Cases Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=1191934359","media":"Reuters","summary":"April 5 (Reuters) - The U.S. health regulator said on Tuesday GlaxoSmithKline and Vir Biotechnology'","content":"<html><head></head><body><p>April 5 (Reuters) - The U.S. health regulator said on Tuesday GlaxoSmithKline and Vir Biotechnology's antibody therapy was no longer authorized as a COVID-19 treatment, with data suggesting it was unlikely to be effective against the dominant Omicron sub-variant in the country.</p><p>The move by the agency, which had already pulled its authorization for the sotrovimab therapy in much of the U.S. northeast last month, sent shares in Vir Biotechnology 11.5% lower.</p><p>The highly contagious BA.2 coronavirus sub-variant is estimated to make up about three of every four COVID-19 cases in the United States, according to the latest government data.</p><p>GlaxoSmithKline and Vir have said treatment with sotrovimab retains neutralizing activity against the BA.2 sub-variant, but others, including researchers from Columbia University, disagree.</p><p>Vir Biotechnology in a filing with the Securities and Exchange Commission said the two companies were preparing a package of data to support the use of a higher dose of sotrovimab for the Omicron BA.2 sub-variant, which will be shared with regulators globally, reiterating the companies' plan from last month.</p><p>Vir still expects to recognize about $1.1 billion in collaboration revenue when sotrovimab doses are delivered in the first half of 2022.</p><p>The companies also plan to submit an application for full approval of the drug in the second half of the year, and expect to start two late-stage trials in the second quarter to assess whether sotrovimab can prevent symptomatic COVID-19 infection in immunocompromised patients, Vir said.</p><p>GSK spokeswoman Lyndsay Meyer said the company will continue to work with governments and health systems, and ensure ongoing access to sotrovimab.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Pulls Authorization for GSK-Vir's COVID Therapy as BA.2 Cases Rise</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Pulls Authorization for GSK-Vir's COVID Therapy as BA.2 Cases Rise\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-04-06 11:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>April 5 (Reuters) - The U.S. health regulator said on Tuesday GlaxoSmithKline and Vir Biotechnology's antibody therapy was no longer authorized as a COVID-19 treatment, with data suggesting it was unlikely to be effective against the dominant Omicron sub-variant in the country.</p><p>The move by the agency, which had already pulled its authorization for the sotrovimab therapy in much of the U.S. northeast last month, sent shares in Vir Biotechnology 11.5% lower.</p><p>The highly contagious BA.2 coronavirus sub-variant is estimated to make up about three of every four COVID-19 cases in the United States, according to the latest government data.</p><p>GlaxoSmithKline and Vir have said treatment with sotrovimab retains neutralizing activity against the BA.2 sub-variant, but others, including researchers from Columbia University, disagree.</p><p>Vir Biotechnology in a filing with the Securities and Exchange Commission said the two companies were preparing a package of data to support the use of a higher dose of sotrovimab for the Omicron BA.2 sub-variant, which will be shared with regulators globally, reiterating the companies' plan from last month.</p><p>Vir still expects to recognize about $1.1 billion in collaboration revenue when sotrovimab doses are delivered in the first half of 2022.</p><p>The companies also plan to submit an application for full approval of the drug in the second half of the year, and expect to start two late-stage trials in the second quarter to assess whether sotrovimab can prevent symptomatic COVID-19 infection in immunocompromised patients, Vir said.</p><p>GSK spokeswoman Lyndsay Meyer said the company will continue to work with governments and health systems, and ensure ongoing access to sotrovimab.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GSK":"葛兰素史克","VIR":"Vir Biotechnology, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191934359","content_text":"April 5 (Reuters) - The U.S. health regulator said on Tuesday GlaxoSmithKline and Vir Biotechnology's antibody therapy was no longer authorized as a COVID-19 treatment, with data suggesting it was unlikely to be effective against the dominant Omicron sub-variant in the country.The move by the agency, which had already pulled its authorization for the sotrovimab therapy in much of the U.S. northeast last month, sent shares in Vir Biotechnology 11.5% lower.The highly contagious BA.2 coronavirus sub-variant is estimated to make up about three of every four COVID-19 cases in the United States, according to the latest government data.GlaxoSmithKline and Vir have said treatment with sotrovimab retains neutralizing activity against the BA.2 sub-variant, but others, including researchers from Columbia University, disagree.Vir Biotechnology in a filing with the Securities and Exchange Commission said the two companies were preparing a package of data to support the use of a higher dose of sotrovimab for the Omicron BA.2 sub-variant, which will be shared with regulators globally, reiterating the companies' plan from last month.Vir still expects to recognize about $1.1 billion in collaboration revenue when sotrovimab doses are delivered in the first half of 2022.The companies also plan to submit an application for full approval of the drug in the second half of the year, and expect to start two late-stage trials in the second quarter to assess whether sotrovimab can prevent symptomatic COVID-19 infection in immunocompromised patients, Vir said.GSK spokeswoman Lyndsay Meyer said the company will continue to work with governments and health systems, and ensure ongoing access to sotrovimab.","news_type":1,"symbols_score_info":{"VIR":0.9,"GSK":0.9}},"isVote":1,"tweetType":1,"viewCount":1878,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9016190218,"gmtCreate":1649139517940,"gmtModify":1676534458310,"author":{"id":"3567748507194894","authorId":"3567748507194894","name":"Snoopdog","avatar":"https://static.tigerbbs.com/8620e2cb2714470a199bcb823c9be5ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3567748507194894","authorIdStr":"3567748507194894"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9016190218","repostId":"2224132370","repostType":4,"repost":{"id":"2224132370","kind":"highlight","pubTimestamp":1649120728,"share":"https://ttm.financial/m/news/2224132370?lang=&edition=fundamental","pubTime":"2022-04-05 09:05","market":"us","language":"en","title":"3 High-Yield Dividend Stocks to Buy in a Market Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=2224132370","media":"Motley Fool","summary":"It could be a good time to lock in these high yields.","content":"<div>\n<p>Bad news tends to overshadow good news. That's especially the case when there has been a lot of bad news in recent weeks as we have experienced. However, there's now good news as well. The major stock...</p>\n\n<a href=\"https://www.fool.com/investing/2022/04/04/3-high-yield-dividend-stocks-to-buy-in-a-market-re/\">Web Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 High-Yield Dividend Stocks to Buy in a Market Rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 High-Yield Dividend Stocks to Buy in a Market Rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-05 09:05 GMT+8 <a href=https://www.fool.com/investing/2022/04/04/3-high-yield-dividend-stocks-to-buy-in-a-market-re/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Bad news tends to overshadow good news. That's especially the case when there has been a lot of bad news in recent weeks as we have experienced. However, there's now good news as well. The major stock...</p>\n\n<a href=\"https://www.fool.com/investing/2022/04/04/3-high-yield-dividend-stocks-to-buy-in-a-market-re/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BRK.B":"伯克希尔B","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","REIT":"ALPS Active REIT ETF","BRK.A":"伯克希尔","BK4176":"多领域控股","BK4550":"红杉资本持仓"},"source_url":"https://www.fool.com/investing/2022/04/04/3-high-yield-dividend-stocks-to-buy-in-a-market-re/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2224132370","content_text":"Bad news tends to overshadow good news. That's especially the case when there has been a lot of bad news in recent weeks as we have experienced. However, there's now good news as well. The major stock market indices have been rising. None of them are in a bear market now -- and the S&P 500 is no longer in correction territory.Income investors could especially have a great opportunity to lock in attractive dividend yields right now. Here are three high-yield dividend stocks to buy in a market rebound.1. Enterprise Products PartnersEnterprise Products Partners didn't sink as most stocks have in recent months. The major midstream energy company's shares are up close to 18% year to date.This solid gain makes sense considering the current overall dynamics of the oil and gas industry. Prices have risen in part due to worries about the Russian invasion of Ukraine. However, the demand for oil and gas has also increased as the global economy recovers from the impact of the COVID-19 pandemic.Enterprise has been a key beneficiary of these tailwinds with its pipelines, natural gas processing facilities, and storage facilities. It should also profit further if the stock market continues to rebound and economic uncertainties fade. But even if not, Enterprise is a stock that should hold up well no matter what the market does.The company offers a juicy dividend yield of 7.2%. Enterprise has also increased its distribution for 23 consecutive years. There aren't too many high-yield dividend stocks with such an impressive track record.2. Medical Properties TrustMedical Properties Trust stock hasn't fared quite so well. Its shares are still down around 9% year to date after beginning to bounce back in mid-March. However, the company's underlying business hasn't skipped a beat.That underlying business is owning and leasing hospitals. Medical Properties Trust is a real estate investment trust (REIT) with around 440 facilities in its portfolio. Roughly 60% of these properties are in the U.S. with the remaining hospitals in eight other countries -- primarily in Europe.As you might expect, Medical Properties Trust's lease revenue doesn't rise or fall based on stock market gyrations. Higher inflation rates shouldn't be a big problem, either. The REIT has rent escalators based on the Consumer Price Index built into more than 99% of its leases.REITs are known for their dividends. Medical Properties Trust is no slouch on that front. Its dividend yield currently stands at nearly 5.5%. The company has increased its dividend for eight consecutive years.3. Verizon CommunicationsVerizon Communications claims a distinction that very few high-yield dividend stocks have: It's one of Warren Buffett's favorites. The telecom giant ranks as the eighth-largest holding in Berkshire Hathaway's portfolio.Should you buy Verizon just because Buffett likes it? Of course not. However, it's a good idea to at least consider what an investor such as the Oracle of Omaha might find attractive about Verizon.The dividend certainly stands out. Verizon's dividend yield tops 5%. The company has increased its dividend for 15 consecutive years. Verizon should easily be able to keep that streak going with a payout ratio of less than 48%.Sure, Verizon probably won't deliver sizzling growth. However, the company could have better growth opportunities than you might think with its high-speed 5G network, especially in expanding further in the home internet market. There's more good news for Verizon than there is bad news.","news_type":1,"symbols_score_info":{"BRK.B":0.76,"REIT":1,"BRK.A":0.76}},"isVote":1,"tweetType":1,"viewCount":3171,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}